OTCM
CGSBF
Market cap2.15bUSD
, Last price
USD
Name
Corporativo Fragua SAB de CV
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Corporativo Fragua, S.A.B. de C.V. is a holding company that operates a chain of pharmacy stores in Mexico under the Farmacias Guadalajara brand. The company is engaged in the retail of medicines, perfumes, photography equipment, household goods, food, and other miscellaneous items. It also provides various services including maintenance, surveillance, medical services, and logistics.
Key people
Javier Arroyo Chavez
Chairman of the Board, Proprietary Director · since 2023
Maria Fernanda Garcia Orozco
Chief Financial Officer · since 2016
Ivan Acuna Regato
Chief Operating Officer
Margarita Paloma Farias Gonzalez
Chief Human Resources Officer · since 2016
Juan Orrante Cervantes
Chief Information Technology Officer
Irene Belloso Villalvazo
Chief Accounting Officer
Enrique Lara Valdez
General Manager - Photosystems
Clemente Guillermo Ledon Fernandez
General Manager of Inomex
Jesus Zuniga Rivera
General Manager of Trate Logistica
Jose Antonio Jimenez Garcia
Manager - Corporate Treasury · since 2020
Javier Arroyo Navarro
General Director · since 2020
Francisco Arroyo Jimenez
Executive Director · since 2023
Rodrigo Arroyo Jimenez
Executive Director · since 2023
Patricia Arroyo Navarro
Executive Director · since 2020
Hector H. Rodriguez Bautista
Director - Sales Point
Juan Carlos Castaneda De La Torre
Manager of Cedis Occidente
Mariana Fernandez Pino
Manager - Strategic Analysis
Lluvia Guadalupe Fierro Salas
Chief Development Officer · since 2015
Jaime Garay Nuno
Corporate Representative · since 2021
Emanuel Garcia Bayardo
Manager of Cedis Noreste
IPO date
Oct 03, 1997
Employees
Domiciled in
MX
Incorporated in
MX
Valuation
Title MXN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||